Discontinued — last reported Q3 '24
Operating
Change in Accrued Liabilities
Roivant Sciences Change in Accrued Liabilities increased by 352.9% to $63.23M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2021 to FY 2023), Change in Accrued Liabilities shows a downward trend with a -10.9% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2024
How to read this metric
An increase represents a source of cash through deferred payment, while a decrease represents a cash outflow as obligations are settled.
Detailed definition
Reflects the change in obligations for expenses incurred but not yet invoiced or paid, such as employee compensation, ta...
Peer comparison
Standard operating cash flow component found in almost all corporate financial statements.
Metric ID:
change_in_accrued_liabilitiesHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$7.34M | $25.91M | $17.01M | $15.02M | -$18.18M | $19.62M | $4.26M | $33.25M | -$49.96M | $37.57M | -$3.40M | $55.94M | -$37.58M | -$3.03M | -$25.00M | $63.23M |
| QoQ Change | — | +453.0% | -34.4% | -11.7% | -221.0% | +208.0% | -78.3% | +681.5% | -250.2% | +175.2% | -109.0% | >999% | -167.2% | +91.9% | -724.3% | +352.9% |
| YoY Change | — | — | — | — | -147.6% | -24.3% | -75.0% | +121.4% | -174.9% | +91.4% | -179.8% | +68.2% | +24.8% | +10.7% | +33.5% | — |
Range-$49.96M – $63.23M
CAGR+77.6%
Avg YoY Growth-22.9%
Median YoY Growth+10.7%
Change in Accrued Liabilities at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's change in accrued liabilities?
- Roivant Sciences (ROIV) reported change in accrued liabilities of $63.23M in Q1 2026.
- What is the long-term trend for Roivant Sciences's change in accrued liabilities?
- Over 2 years (2021 to 2023), Roivant Sciences's change in accrued liabilities has grown at a -10.9% compound annual growth rate (CAGR), from $50.60M to $40.15M.
- What does change in accrued liabilities mean?
- The net change in expenses that have been recognized but not yet paid.